IMRX
#3238
Immuneering Corporation - Class A Common Stock
5.2 4 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.55%
Monthly Change
+22.43%
6 month change
+17.49%
Year Change
+25.06%
Previous Close
5.1 6
Open
5.2 4
Low
5.2 2
High
5.2 5
Volume
95
Financials
- Market Capitalization 339.01 M
- Employee 55
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.18
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3217 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.78 USD | +1.09% | -2.05% | +21.85% | -3.21% | 341.41 M USD | ||
| 3230 |  HELP Cybin Inc. - Common Stock | 6.71 USD | +0.15% | +10.36% | +52.50% | -25.20% | 346.45 M USD | ||
| 3242 |  GALT Galectin Therapeutics Inc. - Common Stock | 5.20 USD | +13.04% | +13.04% | +94.03% | +76.87% | 342.46 M USD | ||
| 3254 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.63 USD | +0.22% | -2.32% | +19.33% | +237.96% | 329.59 M USD |
Frequently asked questions about Immuneering Corporation - Class A Common Stock
What is the Immuneering Corporation - Class A Common Stock stock price today?
The current price of Immuneering Corporation - Class A Common Stock (IMRX) is 5.24. Over the past 24 hours, the stock has changed by +1.55%. Follow the IMRX chart for real-time price dynamics.
What is the stock ticker of Immuneering Corporation - Class A Common Stock?
Immuneering Corporation - Class A Common Stock trades under the ticker IMRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immuneering Corporation - Class A Common Stock stock going up?
IMRX has changed by +0.77% over the last week, +22.43% over the last month, and +25.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immuneering Corporation - Class A Common Stock net income for the last quarter?
Immuneering Corporation - Class A Common Stock reported net income of -13.46 M for the last quarter. The previous quarter showed -11.58 M, which means net income changed by -16.24%.
How many employees does Immuneering Corporation - Class A Common Stock have?
As of the latest available data, Immuneering Corporation - Class A Common Stock has 55 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immuneering Corporation - Class A Common Stock stock?
You can buy Immuneering Corporation - Class A Common Stock (IMRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immuneering Corporation - Class A Common Stock stock?
Investing in Immuneering Corporation - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMRX chart and related analysis on metatrader.com as part of your research.